New Blood Test Quickly Predicts Ibrance Treatment Response in Breast Cancer Patients, Study Shows
News
A new blood test could predict how a patient will respond to metastatic breast cancer medication Ibrance (palbociclib) months earlier than current approaches, a U.K. study suggests. Research shows the ... Read more